Clinical Trials
3 trialsNCT00255801 2018-08-16
Liposomal Doxorubicin Followed By Bexarotene in Treating Patients With Cutaneous T-Cell Lymphoma
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT01504490 2017-02-14
Phase I Study of CS-7017 and Bexarotene
Georgetown University
Phase 1 Terminated
NCT00660231 2014-12-03
GemBex
University College, London
Phase 2 Completed